250
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy

, , , , , , , , , , , , , , & show all
Pages 3259-3262 | Received 15 Jun 2020, Accepted 27 Jul 2020, Published online: 28 Aug 2020
 

Acknowledgments

We are thankful to our patient who consented to additional genetic analysis and to the full report of her case. We are grateful to Drs. Françoise Norol (Apheresis unit, Pitié-Salpétrière Hospital, AP-HP, Paris, France) and Chloé Couzin (Cell therapy unit, Necker Hospital, AP-HP, Paris, France) for the cryopreservation of CD34-positive apheresis samples.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

Seiamak Bahram’s laboratory is supported by grants from the Agence Nationale de la Recherche (ANR) (ANR-11-LABX-0070_TRANSPLANTEX), the INSERM (UMR_S 1109), the Institut Universitaire de France (IUF), the University of Strasbourg (IDEX UNISTRA), the European regional development fund (European Union) INTERREG V program (project n°3.2 TRIDIAG) and MSD-Avenir grant AUTOGEN.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.